Lv7
4900 积分 2024-09-15 加入
CDK4/6 inhibition in hormone receptor-positive/HER2-negative breast cancer: Biological and clinical aspects
1个月前
已完结
Distribution of lymphocyte subsets following radiation therapy directed to different body regions
1个月前
已关闭
Immunosuppression in irradiated breast cancer patients: in vitro effect of cyclooxygenase inhibitors
1个月前
已关闭
Radiotherapy and persistent reduction of peripheral T cells
1个月前
已关闭
CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer
1个月前
已完结
Safety and Efficacy of the mTOR Inhibitor, Vistusertib, Combined With Anastrozole in Patients With Hormone Receptor−Positive Recurrent or Metastatic Endometrial Cancer
1个月前
已完结
Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study
1个月前
已完结
CD4 lymphopenia to identify end-of-life metastatic cancer patients
1个月前
已完结
Patients with metastatic breast cancer leading to CD4+ T cell lymphopaenia have poor outcome
1个月前
已完结
Lymphopenia: A new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma
1个月前
已完结
皖公网安备34019202002308
